Lastest News


MOHW starts study for Public Pharmaceutical Company Control Tower to supply and control national essential drugs

It seems a study will be conducted to check possibility of having a control tower for the National Essential Pharmaceutical Product and public pharmaceutical companies. Even at a recent confirmation hearing, Neung-Ho...

MFDS constructs support system for Korean pharmas to enter international market using position as PIC/S member

The Ministry of Food and Drug Safety(MFDS) will construct a support system of Korean pharmaceutical companies to enter the overseas market by using the position as a PIC/S member. According to the MFDS, ratings of Ko...

Drug stores record highest sales and operating profits in franchise field

Among major franchise types, the pharmaceutical field is observed to record the highest sales and operating profits compared to others. Recently published by the National Statistical Office(NSO), the ‘Franchise Stati...

Will Pfizer become a new power in health functional food market with new ‘Centrum’?

Pfizer will release 6 new types of ‘Centrum’ to successfully settle in the health function food market. The consumer healthcare department of Pfizer Pharmaceuticals Korea(CEO/President Dong-Wook Oh) held a press conf...

Japanese pharmas stingy in donating money as social contributions

Although Japanese pharmaceutical companies branching in Korea are growing up with product quality and marketing power, they are criticized to neglect social contributions of corporate profit, which are a fundamental d...

No exception in using name similar to drug or substance

A legal interpretation was made that there was no exception in using a name similar to a name of drug or substance unless it is a pharmaceutical manufacturer, such as pharmaceutical company. The Ministry of Governmen...

Health-related government tasks unveiled

The government suggested 70% for the National Health Insurance coverage by 2020 as a government project. It will also set up the role of primary medical institute and large hospital and strengthen medical publicity by...

MFDS raises transparency of approval and evaluation for drugs and biologics

The Ministry of Food and Drug Safety(MFDS) will adopt and run the ‘electronic recording system for civil affairs’ to raise transparency of the drug and biologic approval evaluation process. The MFDS announced to cond...

MFDS’s plan to create GMP evaluation system meeting international standards, such as PIC/s

In order to establish a GMP manufacturing facility control system that meets the international standards, such as PIC/s, the Ministry of Food and Drug Safety(MFDS) will prepare a new GMP onsite system from the next ye...

Japanese pharmas earn 77 out of selling KRW 1,000

Japanese pharmaceutical companies were observed to generate KRW 77 profits by selling products(including goods and merchandises) worth of KRW 1,000 in the Korean market. Yakup Shinmoon(www.yakup.com) analyzed 2016 au...

Rapid adoption of AI in developing new drugs ahead of Fourth Industrial Revolution

Ahead of the Fourth Industrial Revolution, Korean and foreign pharmaceutical companies are quickly moving forward to utilize artificial intelligence(AI) into developing new drugs. The trend has been highlighted in maj...

Hanmi Pharm registers ‘Esomezol’

‘Esomezol,’ an acid reflux treatment developed by Hanmi Pharm, was registered at the U.S. Pharmacopeial(USP) for the first time as a Korean pharmaceutical company. Esomezol is the Korea’s first incrementally modified ...

“352 Korean clinical trials were approved in 1st half of this year”

The Korea National Enterprise for Clinical Trials(Chairman Dong-Hyun Ji, KoNETC) revealed the pharmaceutical clinical trial registration status in the 1st half of 2017 at ClinicalTrials.gov, the world’s largest clinic...

Japanese pharmas’ rapid growth in Korean pharmaceutical market

Japanese multinational pharmaceutical companies branching in Korea were analyzed to record excellent sales performances last year. Yakup Shinmoon(www.yakup.com) analyzed 2016 audit reports turned in by Korean branche...

Employees at Korean branches of Japanese pharma earn KRW 74 million per employee a year

It was observed employees working at a Korean branch of multinational Japanese pharmaceutical company earns KRW 74 million per employee a year on average, and annual wages of an employee at Takeda Pharmaceuticals Kore...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.